Similar articles

• Acute endophthalmitis following intravitreal triamcinolone acetonide injection.

  Yuen HK, Chan CK, Lam D. Yuen HK, et al. Am J Ophthalmol. 2004 Jun;137(6):1166; author reply 1167. doi: 10.1016/j.ajo.2004.02.069. Am J Ophthalmol. 2004. PMID: 15183833 No abstract available.
• Vitreous wick syndrome--a potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana.

  Chen SD, Mohammed Q, Bowling B, Patel CK. Chen SD, et al. Am J Ophthalmol. 2004 Jun;137(6):1159-60; author reply 1160-1. doi: 10.1016/j.ajo.2004.01.028. Am J Ophthalmol. 2004. PMID: 15183823 No abstract available.
• Acute endophthalmitis following intravitreal triamcinolone acetonide injection.

  Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP, Kaiser RS, Bakri SJ, Maturi RK, Belmont J, Beer PM, Murray TG, Quiroz-Mercado H, Mieler WF. Moshfeghi DM, et al. Am J Ophthalmol. 2003 Nov;136(5):791-6. doi: 10.1016/s0002-9394(03)00483-5. Am J Ophthalmol. 2003. PMID: 14597028
• Endophthalmitis after intravitreal injections.

  Schwartz SG, Flynn HW, Scott IU. Schwartz SG, et al. Expert Opin Pharmacother. 2009 Sep;10(13):2119-26. doi: 10.1517/14656560903081752. Expert Opin Pharmacother. 2009. PMID: 19586422 Review.
• Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.

  Jonas JB, Kreissig I, Degenring R. Jonas JB, et al. Prog Retin Eye Res. 2005 Sep;24(5):587-611. doi: 10.1016/j.preteyeres.2005.01.004. Epub 2005 Mar 29. Prog Retin Eye Res. 2005. PMID: 16005407 Review.